Mastocytosis: state of the art. (Q34641105)

3 August 2017

1 reference

title

Mastocytosis: state of the art. (English)

1 reference

3 August 2017

Hans-Peter Horny

1

1 reference

3 August 2017

Karl Sotlar

series ordinal

2

1 reference

3 August 2017

Peter Valent

series ordinal

3

1 reference

3 August 2017

publication date

1 January 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

74

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

121-132

1 reference

The growth and differentiation of mast cells

3 August 2017

cites work

1 reference

Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.

21 January 2018

1 reference

Diagnostic criteria and classification of mastocytosis: a consensus proposal

21 January 2018

1 reference

Mast cell proliferative disorders: current view on variants recognized by the World Health Organization

21 January 2018

1 reference

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

21 January 2018

1 reference

Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens.

21 January 2018

1 reference

Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria

21 January 2018

1 reference

Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry

21 January 2018

1 reference

CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.

21 January 2018

1 reference

Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).

21 January 2018

1 reference

One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes

21 January 2018

1 reference

Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia.

21 January 2018

1 reference

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

21 January 2018

1 reference

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

21 January 2018

1 reference

Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.

21 January 2018

1 reference

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

21 January 2018

1 reference

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit

21 January 2018

1 reference

KIT mutations are common in testicular seminomas

21 January 2018

1 reference

Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.

21 January 2018

1 reference

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

21 January 2018

1 reference

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

21 January 2018

1 reference

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

21 January 2018

1 reference

Tryptase a novel biochemical marker of acute myeloid leukemia

21 January 2018

1 reference

Clinical and histopathological aspects of cutaneous mastocytosis

21 January 2018

1 reference

Cutaneous mastocytosis -- clinical heterogeneity.

21 January 2018

1 reference

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

21 January 2018

1 reference

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

21 January 2018

1 reference

Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.

21 January 2018

1 reference

Clinical, genetic, and therapeutic insights into systemic mast cell disease

21 January 2018

1 reference

Mast cell leukemia: report of a case and review of the literature

21 January 2018

1 reference

Mast cell sarcoma of the larynx

21 January 2018

1 reference

Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy

21 January 2018

1 reference

Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?

21 January 2018

1 reference

A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val

21 January 2018

1 reference

"Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.

21 January 2018

1 reference

Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells

21 January 2018

1 reference

Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.

21 January 2018

1 reference

Diagnosis and treatment of systemic mastocytosis: state of the art.

21 January 2018

1 reference

Treatment of systemic mast cell disorders

21 January 2018

1 reference

Mastocytosis: current concepts in diagnosis and treatment

21 January 2018

1 reference

Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients

21 January 2018

1 reference

Response of severe systemic mastocytosis to interferon alpha

21 January 2018

1 reference

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.

21 January 2018

1 reference

Treatment of systemic mast-cell disease with cladribine

21 January 2018

1 reference

Treatment of systemic mast cell disease: beyond interferon

21 January 2018

1 reference

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

21 January 2018

1 reference

Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000101711

1 reference

3 August 2017

1 reference